معرفی
Dr. Paul Armstrong is a Lecturer in Pharmacology at the Centre for Immunobiology within the Blizard Institute at Queen Mary University of London. His research focuses on platelet pharmacology, particularly investigating how platelet turnover in disease states influences thrombotic risk and how platelet-monocyte aggregates contribute to disease pathophysiology. These studies aim to refine therapeutic approaches for cardiovascular diseases.
- Education: BSc in Pharmacology (University of Edinburgh), PhD at William Harvey Research Institute (2009)
- Research Themes: Platelet Reactivity, Thrombosis, Immune Cell Interaction, Cardiovascular Pharmacology
- Collaborations: Timothy D Warner's Lab; international institutions like Baker Institute (Australia)
His recent publications emphasize platelet aging dynamics, noncoding RNA biomarkers, and novel assay development for platelet function testing. Collaborative studies explore cross-disciplinary approaches in thrombosis and hemostasis. No formal student advising or specific grants mentioned in available texts. Armstrong's work frequently addresses antiplatelet therapy optimization and platelet-endothelium interactions.
